Changes in patient-reported outcomes (PROs) and tumor markers (TMs) to predict treatment response and survival outcomes in patients with metastatic gastrointestinal (GI) cancer.Joy X. Jarnagin,Aparna Raj Parikh,Emily E. Van Seventer,Yojan Shah,Islam Baiev,Amirkasra Mojtahed,Jill N. Allen,Lawrence Scott Blaszkowsky,Jeffrey William Clark,Joseph Wang Franses,Bruce J. Giantonio,Lipika Goyal,Samuel J. Klempner,Eric Roeland,David P. Ryan,Colin D. Weekes,Giulia Siravegna,Nora K. Horick,Ryan Bruce Corcoran,Ryan David NippJOURNAL OF CLINICAL ONCOLOGY（2021）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
